Cargando…
Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
Autores principales: | Alvarez-Larrán, Alberto, Díaz-González, Alvaro, Such, Esperanza, Mora, Elvira, Andrade-Campos, Marcio, García-Hernández, Carmen, Gómez-Casares, M. Teresa, García-Gutiérrez, Valentín, Carreño-Tarragona, Gonzalo, Garrote, Marta, Fernández-Ibarrondo, Lierni, Cervera, José, Bellosillo, Beatriz, Cervantes, Francisco, Hernández-Boluda, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862052/ https://www.ncbi.nlm.nih.gov/pubmed/32372025 http://dx.doi.org/10.1038/s41375-020-0849-2 |
Ejemplares similares
-
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
por: Alvarez‐Larrán, Alberto, et al.
Publicado: (2022) -
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
por: Triguero, Ana, et al.
Publicado: (2022) -
Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project
por: Verstovsek, Srdan, et al.
Publicado: (2023) -
Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera
por: Barbui, Tiziano, et al.
Publicado: (2018) -
Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices
por: Kuykendall, Andrew T.
Publicado: (2023)